2017 International Congress

June 4-8, 2017. Vancouver, BC.

View by Title View Sessions

View by Date

Jump to: View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z

Objective biomarkers of posture balance for early and advanced Parkinson’s disease

I. Miliukhina, E. Gracheva, A. Kudrevatykh, T. Sergeev, M. Didur (Saint-Petersburg, Russian Federation)
Objective gait parameters as a noninvasive biomarker for freezing of gait in Parkinson’s disease patients

J. Shah, T. Virmani (Little Rock, AR, USA)
Objective identification of freezing of gait in Parkinson’s disease patients using a triaxial accelerometer

Y. Okuma, H. Mitoma, M. Yoneyama (Izunokuni-city, Japan)
Objective Measurement in Clinical Care of Patients with Parkinson’s disease: an RCT using the PKG

P. Farzanehfar, M. Braybrook, K. Kotschet, M. Horne (Parkville, Australia)
Objective measurement of upper extremity bradykinesia using the keyboard-based dexterity test

S.-k. Song, J.-H. Kang (Jejusi, Republic of Korea)
Observational study of the effectiveness and tolerability of rotigotine+levodopa therapy in older vs younger Parkinson’s disease patients

D. Woitalla, M. Asgharnejad, L. Joeres, J.-C. Schuller, K.R. Chaudhuri (Bochum, Germany)
Occupational Therapy for patients with Parkinson’s disease in the context of Bangladesh

R. Hoque (Dhaka, Bangladesh)
Occupational trichloroethylene exposure and Parkinson’s disease risk

S. Goldman, P. Quinlan, C. Meng, K. Comyns, G.W. Ross, K. Marek, C. Tanner (San Francisco, CA, USA)
Ocular Motor Disorders Among Filipino “LUBAG” or X-Linked Dystonia Parkinsonism (XDP) Patients

M. Macas, E.C. Rossi, S. Abantas-Diamla, A. Punzalan-Sotelo, E. Palisoc, C. Go (Manila, Philippines)
Oculogyric Crisis Due to Treatment With flunarizine

M. Kurtz, D. Ballesteros, J. Crespo, J. Perez Garcia, J. Lopez, I. Lagger, F. Knorre (CF, Argentina)
Off-Target Implications of Nurr1 Agonist Therapy in Parkinson’s disease

K. Steece-Collier, T. Collier, J. Stancati, C. Kemp, B. Daley, C. Sortwell (Grand Rapids, MI, USA)
Olfaction and gustation in patients with Parkinson’s Disease

A. Tautscher-Basnett, V. Tomantschger, M. Freimueller (Hermagor, Austria)
Olfactory deficits in the cognitive impaired de novo patients with Parkinson’s disease

J.S. Baik, H.I. Ma (Seoul, Republic of Korea)
Olfactory dysfunction in patient of Scans Without Evidence of Dopaminergic Deficit with parkinsonian bradykinesia

S.J. Kang, J.Y. Ahn, H.-T. Kim (Seoul, Republic of Korea)
Olfactory Impairment in Parkinson’s Disease and White Matter Abnormalities in Central Olfactory Areas

S. Sobhani, M. Aarabi (Tehran, Islamic Republic of Iran)
ON-time evolution following one-year open-label opicapone: BIPARK-I study

J. Ferreira, A. Lees, O. Rascol, W. Poewe, A. Santos, I. Oliveira, B. Hernandez, F. Rocha, P. Soares-da-Silva (Lisbon, Portugal)
Onabotulinumtoxin A (Botox) displays superior activity to incobotulinumtoxinA (Xeomin) in multiple in vitro and in vivo assays

D. Canty, L. Le, J. Wang, G. Nicholson, A. Brideau-Andersen, L. Steward, B. Jacky, R. Broide, M. Washburn, D. Rupp (Irvine, CA, USA)
Open label study of cannabidiol in Parkinson disease

M. Leehey, Y. LIU, C. EPSTEIN, F. HART, J. BAINBRIDGE, M. COOK, S. SILLAU, Z. BAUD, H. NEWMAN (AURORA, CO, USA)
Optimising STN-DBS frequency parameters for improvement of gait with dual tasking in PD patients

R. Borgohain, R. Kandadai, R.P. Peddisetty, J. Kovvuru, S.S. Meka, R. Alagolu, M. Kannan (Hyderabad, India)
Optimization and evaluation of whole body MRI sequences for patients with deep brain stimulators

C. Drews, S. Wolff, L. Lunden, O. Jansen (Kiel, Germany)
Optimization of Synucleinopathy and Nigrostriatal Degeneration Induced by Injection of Alpha-Synuclein Preformed Fibrils into Rat Striatum

C. Sortwell, T. Collier, M. Duffy, K. Luk, C. Kemp, N. Kanaan, K. Paumier, J. Patterson (Grand Rapids, MI, USA)
Oral health-related quality of life and dental care among Parkinson’s disease patients and Care givers of South India.

E. Aluckal (Ernakulam, India)
Oromandibular dystonia (OMD): A Prospective, Single-Blind Trial of AbobotulinumtoxinA (AboA)

S. Factor, M. Silver, J. Hanfelt, E. Sperine, L. Scorr, A. Freeman, H. Jinnah (Atlanta, GA, USA)
Orthostatic myoclonus after brain tumor surgery and radiation

J. Cutsforth-Gregory, J. Hammack, J. Matsumoto (Rochester, MN, USA)
Oscillatory Activity in the Nucleus Basalis of Meynert

M. Nazmuddin, D. Oterdoom, J. van Zijl, A. Kampman, J. van Dijk, G. Drost, T. van Laar, M. Beudel (Groningen, Netherlands)
Oscillatory dynamics of impaired novelty detection at early Parkinson’s disease

R. Solis-Vivanco, A. Cervantes-Arriaga, M. Rodriguez-Violante (Mexico City, Mexico)
Othello syndrome amongst patients with Parkinson’s disease in a rural movement disorders clinic in western India

S. Desai, D. Desai (Anand, India)
Outcomes of a Prospective, Multicenter International Registry of Deep Brain Stimulation for Parkinson’s Disease

G. Deuschl, R. Jain, H. Scholtes, K. Steinke, A. Wang, A. Kühn, L. Timmermann, M. Pötter-Nerger, P. Eldridge, J. Volkmann, J. Fitzgerald, A. Schnitzler, H. Mehdorn, J. Vesper (Kiel, Germany)

Jump to: View All • a b c d e f g h i j k l m n [o] p q r s t u v w x y z